Consumption of sesame seeds and sesame products has favorable effects on blood glucose levels but not on insulin resistance: A systematic review and meta‐analysis of controlled clinical trials
2022 Jan 18 Phytotherapy Research Sohouli MH, Haghshenas N, Hernández‐Ruiz , Shidfar F
Sesame and its products, including sesame oil, sesamin, and tahini, demonstrated significant positive effects on fasting blood glucose (FBG) levels (WMD: −21.31 mg/dl, 95% CI: −41.23, −1.39, p = .036) and HbA1c (WMD: −0.75, 95% CI: −1.16, −0.34, p < .001). However, results regarding fasting serum insulin (WMD: 5.51 μU/ml,
95% CI: −2.31, 13.33, p = .167) and HOMA-IR (WMD: −0.07, 95% CI: −0.33, 0.20, p = .617) were not statistically significant. In conclusion, sesame may be considered a beneficial agent for human glucose metabolism and can be a valuable component of glucose-lowering diets.
Systematic Review Meta-Analysis Blood Sugar Sesame